KPMG 2025 Global Life Sciences CEO Outlook

Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.

2025 Life Sciences CEO Outlook

Explore how leaders in the sector are navigating industry challenges and shaping their strategies for long-term success.

Download the report

Key findings

Organisations that have already adapted their growth strategies due to interrelated challenges

Life sciences: 80%
Cross sector average: 72%

86%

have a moderate-to-high appetite for M&A over the next three years

25%

integrate the costs and ROI of sustainability initiatives into every major capital investment

73%

expect most corporate staff to be working in hybrid models within three years

India’s life sciences sector is moving from aspiration to execution. CEOs are scaling AI and digital transformation, pursuing M&A with strategic clarity, and investing in workforce skills. By combining innovation with efficiency and leveraging India’s talent base, the industry is positioning itself for sustainable growth and global leadership in a rapidly evolving healthcare and Life Sciences ecosystem

Vijay Chawla

Partner and Head – Life sciences

KPMG in India